{"title":"Urticaire à l’uméclidinium bromure inhalé","authors":"A.M. Rabain , J. Cottin , S. Bauler","doi":"10.1016/j.reval.2024.104169","DOIUrl":null,"url":null,"abstract":"<div><div>We report a case of a man who developed urticaria 48 to 72<!--> <!-->hours after inhaling umeclidinium bromide. Urticaria resolved after discontinuation umeclidinium treatment but recurred on reintroduction. Umeclidinium bromide is an anticholinergic inhaled treatment indicated in the background treatment of COPD, for which marketing authorization was obtained in 2014. The most frequent adverse reactions are: nasopharyngitis, headache, tachycardia, cough or pharyngeal pain, constipation, urinary tract infection or sinusitis. Effects related to antimuscarinic activity are of undetermined frequency. Allergic reactions to this product are rare.</div></div>","PeriodicalId":49130,"journal":{"name":"Revue Francaise d Allergologie","volume":"65 2","pages":"Article 104169"},"PeriodicalIF":0.3000,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue Francaise d Allergologie","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1877032024003907","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
We report a case of a man who developed urticaria 48 to 72 hours after inhaling umeclidinium bromide. Urticaria resolved after discontinuation umeclidinium treatment but recurred on reintroduction. Umeclidinium bromide is an anticholinergic inhaled treatment indicated in the background treatment of COPD, for which marketing authorization was obtained in 2014. The most frequent adverse reactions are: nasopharyngitis, headache, tachycardia, cough or pharyngeal pain, constipation, urinary tract infection or sinusitis. Effects related to antimuscarinic activity are of undetermined frequency. Allergic reactions to this product are rare.
期刊介绍：
La Revue Française d''Allergologie : un véritable forum pour faire connaître des travaux originaux et permettre la diffusion de l''information auprès de toutes les spécialités concernées par les pathologies allergiques. La Revue Française d''Allergologie (8 numéros par an) est au carrefour de nombreuses spécialités - dermatologie, pédiatrie, ORL, pneumologie, ophtalmologie, médecine interne - qui, toutes, ont à traiter des maladies allergiques. Les symptômes des allergies fondés sur des mécanismes communs sont le plus souvent associés et se succèdent chez un même patient. En forte progression depuis 20 ans, les maladies allergiques sont dans l''attente de perfectionnements et d''avancées thérapeutiques qui permettront aux nombreux patients qui en sont atteints de mieux vivre avec leurs allergies. La Revue Française d''Allergologie se veut donc un véritable forum de discussions et d''échanges entre tous les spécialistes confrontés aux pathologies
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
